Nuechterlein Carole
Insider CIK 1665133 · MLND Director · AVXS Director · TRDA Director · ALGS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 5,860 | — | $0 | 5,860 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 5,860 | — | $0 | 5,860 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-06-27 | 2024-06-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 4,411 | — | $0 | 4,411 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 15,000 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | P Buy deriv | 2023-10-25 | 2023-10-27 | 3,966,800 | $0.13 | $515.7K | 3,966,800 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | P Buy | 2023-10-25 | 2023-10-27 | 7,933,601 | $0.76 | $6.03M | 11,025,941 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-07-20 | 2023-07-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 11,918 | — | $0 | 11,918 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2021-10-28 | 2021-11-01 | 23,552 | — | $0 | 23,522 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 283,550 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 2,145,991 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 662,799 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 662,799 | — | $0 | 2,808,790 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 283,550 | — | $0 | 3,092,340 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 2,145,991 | — | $0 | 2,145,991 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2020-06-22 | 2020-06-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2019-06-20 | 2019-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2019-01-15 | 2019-01-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 8,385 | — | $0 | 8,385 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 18,111 | — | $0 | 18,111 | SEC↗ |